We included those aged 45-85 years, living in one of 10 Canadian provinces in between 2012-2015 (at the baseline), recruited via three population-based sampling methods. Insomnia symptoms were assessed using questions adapted/modified from the Pittsburgh Sleep Quality Index. A panel of potential prodromal neurodegenerative markers including self-reported symptoms and objective gait motor, cognitive, and autonomic variables were assessed cross-sectionally. We compared those who endorsed insomnia symptoms ≥3 times per week to controls, adjusting for age, sex and education via logistic regression.
Overall, 2,051/30,097 people screened positive for sleep-onset insomnia alone and 4,333 for sleep-maintenance insomnia alone, while 2,371 endorsed both subtypes. On objective gait tests, participants with sleep-onset insomnia, but not sleep-maintenance insomnia, had worse balance (OR = 1.33[1.16,1.52]) and slower gait speed (OR = 1.52[1.34,1.73]). Although participants with any insomnia subtype endorsed more motor symptoms, these were more severe in those with sleep-onset insomnia (OR onset vs. maintenance = 1.13 [1.07,1.18]). On objective cognitive tests, those with sleep-maintenance insomnia scored normally. However, participants with sleep-onset insomnia performed worse on tests of verbal fluency (OR = 1.24[1.06,1.43]) immediate memory (OR = 1.23[1.08,1.41]), and prospective memory task (OR = 1.29[1.11,1.50]). The sleep-onset insomnia group also had lower heart rate variability (OR = 1.23[1.07,1.43]). Secondary analyses found generally similar results in young vs. older age of insomnia development.
Compared to maintenance insomnia, those with sleep-onset insomnia have more motor, cognitive and autonomic signs/symptoms. When evaluating neurodegenerative risk, differentiating insomnia subtypes may increase precision.
© 2021 American Academy of Sleep Medicine.